Microbot Medical Inc.
MBOT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $91 | $106 | $0 | $0 |
| Gross Profit | -$91 | -$106 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $6,630 | $5,724 | $7,736 | $6,153 |
| G&A Expenses | $4,995 | $4,131 | $5,581 | $5,204 |
| SG&A Expenses | $4,995 | $4,131 | $5,581 | $5,410 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $206 |
| Other Operating Expenses | -$91 | -$106 | -$36 | -$206 |
| Operating Expenses | $11,534 | $9,749 | $13,281 | $11,357 |
| Operating Income | -$11,625 | -$9,855 | -$13,281 | -$11,357 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $182 | -$885 | $113 | $44 |
| Pre-Tax Income | -$11,443 | -$10,740 | -$13,168 | -$11,313 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$11,443 | -$10,740 | -$13,168 | -$11,313 |
| % Margin | – | – | – | – |
| EPS | -0.73 | -1.05 | -1.81 | -1.59 |
| % Growth | 30.5% | 42% | -13.8% | – |
| EPS Diluted | -0.73 | -1.05 | -1.81 | -1.59 |
| Weighted Avg Shares Out | 15,645 | 10,200 | 7,260 | 7,108 |
| Weighted Avg Shares Out Dil | 15,645 | 10,200 | 7,260 | 7,108 |
| Supplemental Information | – | – | – | – |
| Interest Income | $182 | $228 | $54 | $44 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $91 | $106 | $102 | $76 |
| EBITDA | -$11,352 | -$10,634 | -$13,335 | -$11,281 |
| % Margin | – | – | – | – |